DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside

J Transl Med. 2024 Jan 11;22(1):45. doi: 10.1186/s12967-023-04829-6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell- and Tissue-Based Therapy
  • Humans
  • Immunotherapy, Adoptive
  • Neoplasms* / therapy
  • Receptors, Chimeric Antigen*
  • Tumor Microenvironment

Substances

  • Receptors, Chimeric Antigen

Associated data

  • ChiCTR/ChiCTR1900024218
  • ClinicalTrials.gov/NCT06046040